Stevens Capital Management LP bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 23,578 shares of the real estate investment trust's stock, valued at approximately $477,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank acquired a new position in shares of Healthpeak Properties during the 4th quarter valued at $166,804,000. Resolution Capital Ltd acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $122,795,000. Long Pond Capital LP acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $86,885,000. Northern Trust Corp boosted its position in shares of Healthpeak Properties by 32.6% in the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares during the period. Finally, National Bank of Canada FI boosted its position in shares of Healthpeak Properties by 56,120.9% in the fourth quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock worth $34,181,000 after buying an additional 1,683,066 shares during the period. Hedge funds and other institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently issued reports on DOC shares. Argus reissued a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the company from $21.00 to $19.00 in a research note on Tuesday. Evercore ISI lowered their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Robert W. Baird decreased their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "outperform" rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of "Moderate Buy" and a consensus target price of $23.00.
Get Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Performance
DOC traded up $0.27 during midday trading on Wednesday, reaching $17.64. The company had a trading volume of 4,432,498 shares, compared to its average volume of 5,873,857. The stock has a market cap of $12.25 billion, a PE ratio of 73.52, a P/E/G ratio of 1.97 and a beta of 1.03. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.35 and a current ratio of 1.28. The business has a 50-day moving average price of $17.68 and a two-hundred day moving average price of $18.80. Healthpeak Properties, Inc. has a 12-month low of $16.64 and a 12-month high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business's quarterly revenue was down .2% on a year-over-year basis. During the same quarter last year, the company posted $0.45 EPS. On average, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be given a $0.1017 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 6.92%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's payout ratio is presently 508.33%.
Insiders Place Their Bets
In other Healthpeak Properties news, Director Tommy G. Thompson bought 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The shares were bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the transaction, the director directly owned 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Scott M. Brinker bought 2,873 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The stock was acquired at an average price of $17.40 per share, for a total transaction of $49,990.20. Following the transaction, the chief executive officer owned 207,486 shares in the company, valued at $3,610,256.40. This trade represents a 1.40% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 17,100 shares of company stock worth $296,533. 0.23% of the stock is owned by corporate insiders.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.